Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Elena Asensio Martínez"'
Autor:
Luka Mihic-Góngora, Paula Jimenez-Fonseca, Sara Coca-Membribes, Patricia Cruz-Castellanos, Rocío Galán-Moral, Elena Asensio-Martínez, María Palacín-Lois, Alberto Carmona-Bayonas, Cristina Caramés-Sánchez, Caterina Calderon
Publikováno v:
Brain Sciences, Vol 14, Iss 6, p 573 (2024)
As cancer progresses, patients may experience physical decline, which can impair their ability to carry out essential daily tasks. The aim of this study was to analyze the levels of physical activity in patients with advanced cancer undergoing system
Externí odkaz:
https://doaj.org/article/233d913a58364bc9b75d0731ee131530
Autor:
Carles Pericay, Ana Fernández Montes, Vicente Alonso Orduña, Ismael Macias Declara, Elena Asensio Martínez, Nuria Rodríguez Salas, Esperanza Torres, Diego Cacho Lavín, Rosa María Rodríguez Alonso, Esther Falcó, Joan Carles Oliva, Lluis Cirera
Publikováno v:
Cancers, Vol 15, Iss 18, p 4603 (2023)
The retrospective, observational RWD-ACROSS study analyzed disease characteristics, systemic treatment, and survival in patients with metastatic colorectal cancer (mCRC) in Spain. In total, 2002 patients were enrolled (mean age 65.3 years; 62.7% male
Externí odkaz:
https://doaj.org/article/bb8c16485b584e3baf753a7094f3d400
Autor:
Alberto Carmona-Bayonas, Caterina Calderón, Raquel Hernández, Ana Fernández Montes, Beatriz Castelo, Laura Ciria-Suarez, Mónica Antoñanzas, Jacobo Rogado, Vilma Pacheco-Barcia, Elena Asensio Martínez, Alejandra Ivars, Francisco Ayala de la Peña, Paula Jimenez-Fonseca
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-9 (2021)
Abstract Quality of life (QoL) is a complex, ordinal endpoint with multiple conditioning factors. A predictive model of QoL after adjuvant chemotherapy can support decision making or the communication of information about the range of treatment optio
Externí odkaz:
https://doaj.org/article/8239bfeb60044c5d8981d76b9c9a0e1a
Autor:
Laura Ciria-Suarez, Paula Jiménez-Fonseca, María Palacín-Lois, Mónica Antoñanzas-Basa, Ana Fernández-Montes, Aranzazu Manzano-Fernández, Beatriz Castelo, Elena Asensio-Martínez, Susana Hernando-Polo, Caterina Calderon
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0257680 (2021)
BackgroundBreast cancer is one of the most prevalent diseases in women. Prevention and treatments have lowered mortality; nevertheless, the impact of the diagnosis and treatment continue to impact all aspects of patients' lives (physical, emotional,
Externí odkaz:
https://doaj.org/article/39d1feed018b4de9b2b8431619620337
Autor:
Laura Ciria-Suarez, Paula Jiménez-Fonseca, María Palacín-Lois, Mónica Antoñanzas-Basa, Ana Férnández-Montes, Aranzazu Manzano-Fernández, Beatriz Castelo, Elena Asensio-Martínez, Susana Hernando-Polo, Caterina Calderon
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0244355 (2020)
BackgroundThe current cancer care system must be improved if we are to have in-depth knowledge about breast cancer patients' experiences throughout all the stages of their disease.AimThis study seeks to describe breast cancer patients' experience ove
Externí odkaz:
https://doaj.org/article/e36810f4089a4d1ab55511d981d9ad4b
Autor:
Ana Fernández Montes, Vicente Alonso Orduña, Elena Asensio Martínez, Nuria Rodríguez Salas, Esperanza Torres, Diego Cacho Lavín, Rosa María Rodríguez Alonso, Esther Falcó, Joan Carles Oliva, Lluis Cirera, Jesus García Gómez, Carles Pericay
Publikováno v:
The Oncologist.
Background Patients with metastatic colorectal cancer (mCRC) and KRAS mutations have a poor prognosis, seemingly dependent on the location of the mutation. This multicenter, retrospective, cohort study assessed the frequency and prognostic value of s
Autor:
Tania Calvo-López, Mateo Paz-Cabezas, Patricia Llovet, Maria Dolores Ibañez, Javier Sastre, Vicente Alonso-Orduña, J.Ma. Viéitez, Alfonso Yubero, Ruth Vera, Elena Asensio-Martínez, Pilar Garcia-Alfonso, Enrique Aranda, Eduardo Diaz-Rubio, Beatriz Perez-Villamil
Publikováno v:
Cancer Biomarkers. 34:201-210
BACKGROUND: MicroRNAs (miRs) are frequently altered in colorectal cancer (CRC) and can be used as prognostic factors. OBJECTIVE: To confirm in stage III CRC patients a reported miR signature that was associated to the presence of metastatic disease.
Autor:
Raquel Hernández, Elena Asensio Martínez, Ana Montes, Beatriz Castelo, Jacobo Rogado, Alberto Carmona-Bayonas, V. Pacheco-Barcia, Laura Ciria-Suarez, Mónica Antoñanzas, Caterina Calderon, Francisco Ayala de la Peña, Paula Jiménez-Fonseca, Alejandra Ivars
Publikováno v:
NPJ Breast Cancer
Dipòsit Digital de la UB
Universidad de Barcelona
npj Breast Cancer, Vol 7, Iss 1, Pp 1-9 (2021)
Dipòsit Digital de la UB
Universidad de Barcelona
npj Breast Cancer, Vol 7, Iss 1, Pp 1-9 (2021)
Quality of life (QoL) is a complex, ordinal endpoint with multiple conditioning factors. A predictive model of QoL after adjuvant chemotherapy can support decision making or the communication of information about the range of treatment options availa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c065ca38eeab048abab9fdbf5f070b1
http://hdl.handle.net/2445/179373
http://hdl.handle.net/2445/179373
Autor:
Elena Asensio Martínez, Tomás Izquierdo Rus, Andrés Escarbajal Frutos, Javier Rodríguez Moreno
Publikováno v:
Redined, Red de Información Educativa
Ministerio de Educación, Cultura y Deporte (MECD)
DIGITUM. Depósito Digital Institucional de la Universidad de Murcia
instname
Ministerio de Educación, Cultura y Deporte (MECD)
DIGITUM. Depósito Digital Institucional de la Universidad de Murcia
instname
La universidad es un contexto de aprendizaje, en el que el alumnado es el responsable de tomar sus propias decisiones, controlar su propio proceso de aprendizaje y las interacciones que intervienen en él. En los grados como el de Educación Primaria
Autor:
Antonieta Salud, Jorge Barriuso, R. Jimeno, C. Romero, Fernando Rivera, Pilar García-Alfonso, Margarita Reboredo, Mónica Jorge, J. C. Méndez, Elena Asensio Martínez, Nerea Muñoz-Unceta, V. Arrazubi, Marta Izquierdo-Manuel, P. Jiménez-Fonseca, C. Lopez
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose The phase III ToGA trial established cisplatin, fluoropyrimidine and trastuzumab as the standard treatment in HER2-positive advanced gastric cancer (AGC). However, as demonstrated in HER2-negative AGC, oxaliplatin-based regimens could improve